查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807409

抗生素的全球市場:市場規模·佔有率·趨勢，產業分析 (各類藥物·各類型·各作用機制·各地區)，2025年～2034年的市場預測

Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class, By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，抗生素市場規模將達到 758 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

抗生素是一種治療藥物，旨在抑製或消除有害細菌的生長，在醫療環境中控制細菌感染方面發揮核心作用。抗生素市場的發展受到人們對抗生素抗藥性日益增長的擔憂的影響，這重新激發了人們對開發下一代抗生素的興趣。隨著傳統抗生素對不斷進化的細菌菌株逐漸失去效力，製藥公司和研究機構正在加強努力，探索新型化合物和創新治療策略。這種轉變，加上對標靶治療和精準醫療的日益關注，正在重新定義市場格局。

人工智慧和機器學習平台在抗生素研發領域的日益融合也促進了市場成長。這些技術正在加速有前景的候選藥物的識別，優化臨床試驗設計，並增強抗藥性模式的預測模型。數位創新的應用減少了抗生素研發的時間和成本，提高了成功的可能性。因此，技術整合正成為重塑研究管道和拓展抗生素治療未來前景的變革力量。

抗生素市場：分析概述

按類型劃分，仿製抗生素將在2024年佔銷售額的81.48%，這得益於價格實惠、廣泛供應以及領先品牌藥專利到期等因素。

按作用機制劃分，RNA合成抑制劑預計將在預測期內實現最快增長，因為它們能夠精準靶向細菌途徑並對抗抗藥性細菌。

在嚴格的抗生素管理、監測系統和先進的治療創新的支持下，北美將在2024年佔全球抗生素市場的39.36%。

預計在預測期內，亞太市場將顯著增長，這得益於人口增長、醫療基礎設施改善以及人們對傳染病認識的提高。

全球主要市場參與者包括安斯泰來製藥、阿斯特捷利康、西普拉、費森尤斯卡比、葛蘭素史克公司、希特羅醫療有限公司、魯賓製藥、默克公司、輝瑞和梯瓦製藥工業公司。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球抗生素市場洞察

  • 市場概述
  • 抗生素的市場動態
    • 促進因素和機會
      • 人口老化成長
      • 研發進展
    • 限制與課題
      • 低獲利能力所帶來的經濟和金融課題
      • 公眾輿論與隱私先例
  • 大環境分析
  • 抗生素市場趨勢
  • 價值鏈分析

第5章 抗生素市場:各類藥物

  • 主要的分析結果
  • 簡介
  • 頭孢菌素類
  • 青黴素類
  • 氟喹諾酮類
  • 大環內酯類
  • 卡巴培南類
  • 氨基糖苷類
  • 磺胺類
  • 7-ACA
  • 其他

第6章 抗生素市場:各類型

  • 主要的分析結果
  • 簡介
  • 品牌抗生素
  • 非專利抗生素

第7章 抗生素市場:各作用機制

  • 主要的分析結果
  • 簡介
  • 細胞壁合成抑制劑
  • 蛋白質合成抑制劑
  • DNA合成抑制劑
  • RNA合成抑制劑
  • 分枝酸抑制劑

第8章 抗生素市場:各地區

  • 主要的分析結果
  • 簡介
    • 抗生素市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:各類藥物·各地區(2020～2034年)
    • 北美:各類型·各地區(2020～2034年)
    • 北美:各作用機制·各地區(2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類藥物·各地區(2020～2034年)
    • 歐洲:各類型·各地區(2020～2034年)
    • 歐洲:各作用機制·各地區(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類藥物·各地區(2020～2034年)
    • 亞太地區:各類型·各地區(2020～2034年)
    • 亞太地區:各作用機制·各地區(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類藥物·各地區(2020～2034年)
    • 中東·非洲:各類型·各地區(2020～2034年)
    • 中東·非洲:各作用機制·各地區(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類藥物·各地區，2020-2034年
    • 南美:各類型·各地區(2020～2034年)
    • 南美:各作用機制·各地區(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Astellas Pharma Inc.
  • AstraZeneca
  • Cipla
  • Fresenius Kabi AG
  • GSK plc
  • Hetero Healthcare Limited
  • Lupin Pharmaceuticals, Inc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM2083

The antibiotics market size is expected to reach USD 75.80 billion by 2034, according to a new study by Polaris Market Research. The report "Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibiotics are therapeutic agents designed to inhibit the growth of or eliminate harmful bacteria, playing a central role in managing bacterial infections across healthcare environment. The antibiotics market is driven due to the escalating concern over antimicrobial resistance, which is prompting renewed interest in the development of next-generation antibiotics. Pharmaceutical companies and research institutions are intensifying their efforts to discover novel compounds and innovative treatment strategies as traditional antibiotics lose efficacy against evolving bacterial strains. This shift is redefining the market landscape, with a growing focus on targeted therapies and precision medicine.

The increasing integration of artificial intelligence and machine learning platforms in antibiotic discovery and development contributes to the market's growth. These technologies are accelerating the identification of promising drug candidates, optimizing clinical trial design, and enhancing predictive modeling for resistance patterns. The application of digital innovation reduces the time and cost associated with antibiotic development and increases the likelihood of successful outcomes. As a result, technological integration is emerging as a transformative force in reshaping the research pipeline and expanding the future scope of antibiotic therapies.

Antibiotics Market Report Highlights

In terms of type, the generic antibiotics segment held an 81.48% revenue share in 2024, fueled by affordability, broad availability, and patent expirations of major branded drugs.

Based on action mechanism, the RNA synthesis inhibitors segment is anticipated to register the fastest growth during the forecast period, driven by their precision in targeting bacterial pathways and addressing resistance.

North America captured 39.36% of the global antibiotics market in 2024, supported by stringent antibiotic stewardship, surveillance systems, and advanced treatment innovations.

The Asia Pacific market is poised for significant growth during the forecast period, propelled by population growth, improved healthcare infrastructure, and rising infectious disease awareness.

A few global key market players include Astellas Pharma Inc.; AstraZeneca; Cipla; Fresenius Kabi AG; GSK plc; Hetero Healthcare Limited; Lupin Pharmaceuticals, Inc; Merck & Co., Inc.; Pfizer Inc.; and Teva Pharmaceutical Industries Ltd..

Polaris Market Research has segmented the antibiotics market report on the basis of drug class, type, action mechanism, and region:

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Cephalosporin

Penicillin

Fluoroquinolone

Macrolides

Carbapenems

Aminoglycosides

Sulfonamides

7-ACA

Others

By Type Outlook (Revenue, USD Billion, 2020-2034)

Branded Antibiotics

Generic Antibiotics

By Action Mechanism Outlook (Revenue, USD Billion, 2020-2034)

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Mycolic Acid Inhibitors

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Antibiotics Market Insights

  • 4.1. Antibiotics Market - Market Snapshot
  • 4.2. Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Geriatric Population
      • 4.2.1.2. Advancements in Research and Development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Economic and Financial Challenge due to Low Profitability
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibiotics Market Trends
  • 4.6. Value Chain Analysis

5. Antibiotics Market, By Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Antibiotics Market, By Drug Class, 2020-2034 (USD Billion)
  • 5.3. Cephalosporin
    • 5.3.1. Antibiotics Market, by Cephalosporin,2020-2034 (USD Billion)
  • 5.4. Penicillin
    • 5.4.1. Antibiotics Market, by Penicillin,2020-2034 (USD Billion)
  • 5.5. Fluoroquinolone
    • 5.5.1. Antibiotics Market, by Fluoroquinolone,2020-2034 (USD Billion)
  • 5.6. Macrolides
    • 5.6.1. Antibiotics Market, by Macrolides,2020-2034 (USD Billion)
  • 5.7. Carbapenems
    • 5.7.1. Antibiotics Market, by Carbapenems,2020-2034 (USD Billion)
  • 5.8. Aminoglycosides
    • 5.8.1. Antibiotics Market, by Aminoglycosides,2020-2034 (USD Billion)
  • 5.9. Sulfonamides
    • 5.9.1. Antibiotics Market, by Sulfonamides,2020-2034 (USD Billion)
  • 5.10. 7-ACA
    • 5.10.1. Antibiotics Market, by 7-ACA,2020-2034 (USD Billion)
  • 5.11. Others
    • 5.11.1. Antibiotics Market, by Others,2020-2034 (USD Billion)

6. Antibiotics Market, By Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Antibiotics Market, By Type, 2020-2034 (USD Billion)
  • 6.3. Branded Antibiotics
    • 6.3.1. Antibiotics Market, by Branded Antibiotics,2020-2034 (USD Billion)
  • 6.4. Generic Antibiotics
    • 6.4.1. Antibiotics Market, by Generic Antibiotics,2020-2034 (USD Billion)

7. Antibiotics Market, By Action Mechanism

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Antibiotics Market, By Action Mechanism, 2020-2034 (USD Billion)
  • 7.3. Cell Wall Synthesis Inhibitors
    • 7.3.1. Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.4. Protein Synthesis Inhibitors
    • 7.4.1. Antibiotics Market, by Protein Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.5. DNA Synthesis Inhibitors
    • 7.5.1. Antibiotics Market, by DNA Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.6. RNA Synthesis Inhibitors
    • 7.6.1. Antibiotics Market, by RNA Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.7. Mycolic Acid Inhibitors
    • 7.7.1. Antibiotics Market, by Mycolic Acid Inhibitors,2020-2034 (USD Billion)

8. Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Antibiotics Market Assessment, By Geography, by Region, 2020-2034 (USD Billion)
  • 8.3. Antibiotics Market - North America
    • 8.3.1. North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.3.2. North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.3.3. North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.3.4. Antibiotics Market - US
      • 8.3.4.1. US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.3.5. Antibiotics Market - Canada
      • 8.3.5.1. Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.4. Antibiotics Market - Europe
    • 8.4.1. Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.4. Antibiotics Market - UK
      • 8.4.4.1. UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.5. Antibiotics Market - France
      • 8.4.5.1. France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.6. Antibiotics Market - Germany
      • 8.4.6.1. Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.7. Antibiotics Market - Italy
      • 8.4.7.1. Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.8. Antibiotics Market - Spain
      • 8.4.8.1. Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.9. Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.10. Antibiotics Market - Russia
      • 8.4.10.1. Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.11. Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.5. Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.4. Antibiotics Market - China
      • 8.5.4.1. China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.5. Antibiotics Market - India
      • 8.5.5.1. India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.6. Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.7. Antibiotics Market - Japan
      • 8.5.7.1. Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.8. Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.9. Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.10. Antibiotics Market - Australia
      • 8.5.10.1. Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.11. Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.6. Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.4. Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.5. Antibiotics Market - UAE
      • 8.6.5.1. UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.6. Antibiotics Market - Israel
      • 8.6.6.1. Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.7. Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.8. Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.7. Antibiotics Market - Latin America
    • 8.7.1. Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.4. Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.5. Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.6. Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.7. Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Astellas Pharma Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fresenius Kabi AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GSK plc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hetero Healthcare Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lupin Pharmaceuticals, Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck & Co., Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pfizer Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teva Pharmaceutical Industries Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 2 Global Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 3 Global Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 4 North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 5 North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 6 North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 7 US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 8 US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 9 US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 10 Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 11 Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 12 Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 13 Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 14 Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 15 Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 16 UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 17 UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 18 UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 19 France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 20 France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 21 France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 22 Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 23 Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 24 Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 25 Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 26 Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 27 Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 28 Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 29 Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 30 Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 34 Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 35 Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 36 Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 43 China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 44 China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 45 China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 46 India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 47 India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 48 India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 52 Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 53 Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 54 Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 58 South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 59 South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 60 South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 61 Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 62 Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 63 Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 73 UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 74 UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 75 UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 76 Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 77 Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 78 Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 79 South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 80 South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 81 South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 85 Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 86 Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 87 Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 88 Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 89 Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 90 Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 91 Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 92 Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 93 Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 94 Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 95 Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 96 Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Antibiotics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market By Drug Class
  • Figure 7. Antibiotics Market, By Drug Class, 2024 & 2034 (USD Billion)
  • Figure 8. Market By Type
  • Figure 9. Antibiotics Market, By Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market By Action Mechanism
  • Figure 11. Antibiotics Market, By Action Mechanism, 2024 & 2034 (USD Billion)